Antioch, CA, United States of America

Daniel Masao Estandian

USPTO Granted Patents = 4 

Average Co-Inventor Count = 8.0

ph-index = 2

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2025

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Daniel Masao Estandian

Introduction

Daniel Masao Estandian is a notable inventor based in Antioch, California. He has made significant contributions to the field of biotechnology, particularly in protein sequencing. With a total of 4 patents to his name, Estandian's work is paving the way for advancements in molecular biology.

Latest Patents

One of Estandian's latest patents focuses on "Protein sequencing via coupling of polymerizable molecules." This patent outlines methods and systems for sequencing proteins using linkers that have an amino acid-reactive group and an additional reactive moiety. These linkers can couple to a polymerizable molecule and an amino acid of a peptide, followed by cleavage of the amino acid from the peptide. The further processing and analysis can be conducted using nanopores or nanogaps, showcasing Estandian's innovative approach to protein analysis.

Career Highlights

Estandian is currently associated with Glyphic Biotechnologies, Inc., where he continues to develop cutting-edge technologies in the field of biotechnology. His work is instrumental in enhancing the understanding of protein structures and functions, which is crucial for various applications in medicine and research.

Collaborations

Estandian collaborates with talented individuals such as Asmamaw T Wassie and Andrew John Price. Their combined expertise contributes to the innovative environment at Glyphic Biotechnologies, Inc.

Conclusion

Daniel Masao Estandian is a prominent figure in the field of biotechnology, with a focus on protein sequencing. His innovative patents and collaborations are making a significant impact in the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…